Suryadevara, Praveen Kumar published the artcileDialkylimidazole inhibitors of Trypanosoma cruzi sterol 14α-demethylase as anti-Chagas disease agents, Computed Properties of 350-30-1, the publication is Bioorganic & Medicinal Chemistry Letters (2013), 23(23), 6492-6499, database is CAplus and MEDLINE.
New dialkylimidazole based sterol 14α-demethylase inhibitors were prepared and tested as potential anti-Trypanosoma cruzi agents. Previous studies had identified compound I as the most potent and selective inhibitor against parasite cultures. In addition, animal studies had demonstrated that compound I is highly efficacious in the acute model of the disease. However, compound I has a high mol. weight and high hydrophobicity, issues addressed here. Systematic modifications were carried out at four positions on the scaffold and several inhibitors were identified which are highly potent (EC50 <1 nM) against T. cruzi in culture. The halogenated derivatives II (where R2 = Cl, R3 = Me or H; R2 = F, R3 = H) display excellent activity against T. cruzi amastigotes, with reduced mol. weight and lipophilicity, and exhibit suitable physicochem. properties for an oral drug candidate.
Bioorganic & Medicinal Chemistry Letters published new progress about 350-30-1. 350-30-1 belongs to chlorides-buliding-blocks, auxiliary class Fluoride,Chloride,Nitro Compound,Benzene, name is 3-Chloro-4-fluoronitrobenzene, and the molecular formula is C3H6F3N, Computed Properties of 350-30-1.
Referemce:
https://en.wikipedia.org/wiki/Chloride,
Chlorides – an overview | ScienceDirect Topics